Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone for better outcomes in babies with bacterial meningitis
ISRCTN17216564Phase 3Recruiting
- Sponsor
- St George's, University of London
- Start
- Oct 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, open-label trial of dexamethasone in bacterial meningitis (2 arms), sponsored by St George's, University of London. Primary endpoint: Survival without moderate or severe neurodevelopmental impairment. Started Oct 2026; status: recruiting.
02
Drugs
dexamethasone
03
Conditions
bacterial meningitis
Beyond the preview
Go deeper on ISRCTN17216564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN17216564.